Autoimmunity to citrullinated proteins and the initiation of rheumatoid arthritis

Area of Science:

• Immunology
• Rheumatology
• Autoimmune Diseases

Background:

• Rheumatoid arthritis (RA) is a common autoimmune disease primarily affecting joints, leading to disability.
• Current treatments aim to manage symptoms, but the exact cause of RA remains unknown.
• RA is linked to autoimmunity against citrullinated proteins and peptides.

Purpose of the Study:

• To explore the link between autoimmunity to citrullinated antigens and the early development of rheumatoid arthritis.
• To propose a model for understanding the causal mechanisms of RA initiation.
• To connect the presence of specific autoantibodies with the preclinical stages of RA.

Main Methods:

• Review of existing literature on RA etiology and autoimmunity.
• Analysis of the temporal relationship between autoantibody development and clinical RA onset.
• Conceptual modeling of early autoimmune processes in RA pathogenesis.

Main Results:

• Autoimmunity to citrullinated antigens is a key feature in severe RA.
• Anti-citrullinated protein/peptide antibodies are detectable years before clinical RA diagnosis.
• These findings suggest a preclinical autoimmune phase preceding joint inflammation.

Conclusions:

• Autoimmunity to citrullinated antigens plays a critical role in the early pathogenesis of rheumatoid arthritis.
• Understanding this preclinical phase is crucial for identifying RA causal mechanisms.
• This model provides a framework for investigating early RA development and potential interventions.